Immatics
Immatics Logo
About Immatics
Immatics N.V. is a clinical-stage biopharmaceutical company specializing in the research and development of T cell redirecting immunotherapies for cancer treatment. The company focuses on targeted immunotherapies for solid tumors, utilizing TCR-engineered adoptive cell therapies and TCR Bispecifics. Its pipeline includes candidates such as IMA203, IMA203CD8, IMA204, and IMA30x, as well as TCR Bispecifics like IMA401 and IMA402. Immatics collaborates with leading organizations to advance T cell and TCR-based therapies and is headquartered in Tübingen, Germany.
Address
Paul-Ehrlich-Strasse 15,
Tübingen, 72076
Germany
Year founded
1970
Number of employees
300-400
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
